EUROSPINE

EUROSPINE 2022

19–21 October, Milan, Italy

I-FACTOR

www.cerapedics.com Achtung Link öffnet sich in einem neuen Fenster

Cerapedics is an advanced orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. i-FACTOR® Peptide Enhanced Bone Graft (P-15/ABM) is only the second FDA PMA Approved bone graft on the market.
© EUROSPINE, the Spine Society of Europe - website by bestview gmbh page last updated on 13.05.2022